Dr. Kapadia reports Mohs micrographic surgery comes with a 99 percent cure rate for patients suffering from basal cell carcinoma of the eyelid
Wellesley, MA -- (SBWIRE) -- 10/02/2014 -- Eyelid cancer accounts for approximately five to ten percent of skin cancers and 90 percent of patients diagnosed with this type of skin cancer find theirs is of the basal cell carcinoma type. When detected and treated early, patients find this type of cancer is typically curable, yet the significant risk of damage to nearby ocular structures remains of concern. Some patients find the cancer leads to blindness, when the tumor isn't removed in a timely manner. For this reason, individuals need to ensure they seek treatment when a scar-like texture or appearance develops on an eyelid or a tumor begins to develop.
"Early treatment reduces the risk of damage to structures of the eye, which is why this campaign is of great importance. Eyelid skin cancers typically appear on the lower lid or the area between the inner corner of the eye and the bridge of the nose. Cancers also develop on the upper eyelid, the eyebrow, and the outer corner of the eye, although these areas tend to be affected less frequently," Dr. Mitesh Kapadia declares.
Dr. Kapadia makes use of Mohs micrographic surgery to remove cancerous areas, as this surgical procedure tends to be the most effective treatment for cancers of this type. Mohs micrographic surgery allows for microscopic control over which tissues are excised, as the surgeon removes thin layers of the tissue which is affected. The surgeon then freezes the tissues before microscopically checking the undersurface and edges of the layers. This allows for the minimum amount of tissue to be removed, while offering the best results cosmetically. In addition, patients find Mohs micrographic surgery preserves more function than other treatment options.
"Studies show this surgery to be very effective for the treatment of basal cell carcinoma of the eyelid. Researchers looked at 1,773 cases of this type of eyelid cancer and found that it comes with a 99 percent five year cure rate. This is in contrast to standard modalities, including radiation therapy and traditional surgical incision, which come with a recurrence rate of five to 30 percent," Dr. Kapadia continues.
In addition to offering Mohs micrographic surgery for basal cell carcinoma of the eyelid, Dr. Kapadia provides many other services to patients. He assists those suffering from droopy eyelids, puffy eyes, dark circles under the eyes, and more. Individuals in need of reconstructive eyelid surgery turn to Dr. Kapadia for assistance, and the same is true of those wishing to have cosmetic botox injections.
"Don't trust the eyes to any doctor. Ocular structures remain very delicate, and the skill of the physician plays a major role in the success of any treatment. Contact our office today and we will be happy to discuss any issues you are having. Never delay seeking treatment for a problem with the eyes or eyelids, as our office can be of assistance with a wide variety of conditions," Dr. Kapadia states.
About Mitesh Kapadia, MD, PhD
Dr. Mitesh Kapadia, an ophthalmic plastic surgeon, specializes in reconstructive and cosmetic eyelid surgery, along with lacrimal (tear duct) and orbital surgery. Dr. Kapadia offers minimally invasive rejuvenation using Botox and various facial fillers like Juvederm and Restylane along with his surgical skills, and is a recognized leader in his field. In addition to assisting patients, Dr. Kapadia teaches at Tufts University School of Medicine and has authored a number of textbook chapters and research publications. He continues as a member of the American Academy of Ophthalmology and remains board certified in Ophthalmology.